Nature Communications (Feb 2021)

Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology

  • Vincent L. Chen,
  • Xiaomeng Du,
  • Yanhua Chen,
  • Annapurna Kuppa,
  • Samuel K. Handelman,
  • Rishel B. Vohnoutka,
  • Patricia A. Peyser,
  • Nicholette D. Palmer,
  • Lawrence F. Bielak,
  • Brian Halligan,
  • Elizabeth K. Speliotes

DOI
https://doi.org/10.1038/s41467-020-20870-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Serum liver enzyme concentrations are the most frequently-used laboratory markers of liver disease, a major cause of mortality. We conduct a meta-analysis of genome-wide association studies of liver enzymes from UK BioBank and BioBank Japan. We identified 160 previously-unreported independent alanine aminotransferase, 190 aspartate aminotransferase, and 199 alkaline phosphatase genome-wide significant associations, with some affecting multiple different enzymes. Associated variants implicate genes that demonstrate diverse liver cell type expression and promote a range of metabolic and liver diseases. These findings provide insight into the pathophysiology of liver and other metabolic diseases that are associated with serum liver enzyme concentrations.